“…However, the presence of folate receptor autoantibodies, oxidative stress and secondary inflammatory responses are able to block folate transfer across the choroid plexus to the CNS. Such primary and secondary forms of cerebral folate deficiency (CFD) with an encephalopathic symptomatology have extensively been described in the infantile-onset CFD syndrome [14], mitochondrial encephalopathies [15], Kearns-Sayre syndrome [16], Rett syndrome [17,18], and Aicardi-Goutières syndrome [19]. The use of antifolate drugs in rare inborn errors of metabolism like deficiency of dihydropteridine reductase, methylenetetrahydrofolate reductase, aromatic aminoacid decarboxylase and 3-phosphoglycerate dehydrogenase should be excluded [14].…”